Log In
Print
BCIQ
Print
Print this Print this
 

Inhaled ISIS (AZD1419)

  Manage Alerts
Collapse Summary General Information
Company Dynavax Technologies Corp.
DescriptionToll-like receptor 9 (TLR9) agonist
Molecular Target Toll-like receptor 9 (TLR9)
Mechanism of ActionToll-like receptor 9 (TLR9) agonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationAsthma
Indication DetailsTreat asthma
Regulatory Designation

Partner

AstraZeneca plc


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today